在上皮细胞中由 ангиотензин II 诱导的铁死通过 SP1-DPEP1-中介 SLC3A2 降解导致脏损伤
Yuan Tian1,2, Ge Yang1, Qihe Zhang1
1Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, China.
Diabetes
|January 6, 2026
概括
ангиотензин II (AngII) 通过铁亡,细胞死亡过程触发损伤. 向二酶1 (DPEP1) 抑制了这种铁亡,为AngII诱导的损伤提供了新的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- ангиотензин II (AngII) 激活是糖尿病病原和损伤的关键驱动因素,通常涉及氧化应激和炎症.
- 铁,一种依赖于铁的调节细胞死亡,在损伤中起着重要作用,但其对AngII诱导损伤的具体贡献尚未完全理解.
研究的目的:
- 为了探索铁亡对AngII诱导的损伤的贡献.
- 在这种情况下,研究铁灭的调节机制,重点关注二酶1 (DPEP1).
主要方法:
- 评估功能障碍标志物 (血清肌素,尿蛋白与肌素的比率) 作为对慢性AngII刺激的反应.
- 研究了管性上皮细胞 (TEC) 中的铁亡和DPEP1的作用,使用铁亡抑制剂 (Fer-1),DPEP1基因沉默和DPEP1抑制剂 (cilastatin).
- 研究了涉及转录因子SP1和SLC3A2转运器的分子机制.
主要成果:
- 慢性AngII刺激导致功能障碍和管状损伤,与TECs中的铁亡以及DPEP1表达的增加有关.
- 铁素-1 (Fer-1) 逆转了铁亡并改善了功能.
- 通过DPEP1抑制 (通过基因沉默或基拉斯塔丁) 通过防止SLC3A2无化和谷氨耗尽,显著减少AngII诱导的铁化.
- 通过SP1,AngII通过SP1调节了DPEP1,导致SLC3A2无化和铁亡.
结论:
- 铁亡是AngII诱导的损伤的一个关键媒介.
- SP1-DPEP1-SLC3A2轴是AngII诱导的铁亡的一个关键途径.
- 向DPEP1代表了对AngII驱动的损伤在诸如高血压和代谢障碍等疾病中的有前途的治疗策略.
更多相关视频
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.8K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
861
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Acute Kidney Injury II: Pathophysiology
870
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
870
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
